Experience 3C Patch Wound Management – The novel 3-layer leukocyte, platelets, and fibrin patch that draws on each patient’s unique ability to help their healing process
Clinical evidence from a large (n=269) international randomized controlled trial published in the Lancet (2018) confirms 3C Patch has a strong clinical efficacy on chronic diabetic foot ulcers compared to standard of care.1
Effective April 13, 2021, Medicare covers the 3C Patch for the treatment of chronic non-healing diabetic wounds for
20 weeks.2
The International Working Group of the Diabetic Foot recommends the use of 3C Patch - an autologous multilayer leukocyte, platelet, and fibrin patch as adjunctive treatment in diabetic foot ulcers that are difficult to heal3
The Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) taking place May 14-18, 2024 in Orlando, FL, is the leading meeting dedicated to the management, treatment, and prevention of wounds. The expert line-up of faculty, depth of discussions, and exposure to evidence-based practices and techniques are unparalleled. You'll receive invaluable wound care education that you can apply to practice to improve the lives of your patients. Register Now
15-20 MINUTES – the approximate time it takes to produce a 3C Patch®
18ml of blood is collected into the 3C Patch® device by vacuum. The device is placed into the centrifuge to generate a 3C Patch®.
The blood cells are separated into three layers using a proprietary process controlled by the centrifuge.
The filter is released to compact the leukocytes, platelets and fibrin creating the 3-layer patch.
Histological image highlighting the three layers of the 3C Patch.
Open the device and remove the 3C Patch®.
Place the 3C Patch® filter side up on a sterile absorbing surface.
Apply the filter side (checkered side) of the patch directly to the wound surface. The 3C Patch® may overlap intact skin.
Cover the 3C Patch® with the supplied primary dressing. Apply a secondary absorbent dressing (free choice, depending on the amount of exudate).
Lake Charles, LA (KPLC) - Have you ever had a wound that just wouldn’t go away? Such wounds aren’t just painful, they can be downright dangerous, especially for diabetics. One Southwest Louisiana is sharing his long journey to healing and the new treatment that’s offering hope to others.
Watch VideoThe efficacy and regenerative capability of 3C Patch® is supported by solid clinical results, including a large scale randomized controlled trial (RCT) published in the highly recognized medical journal The Lancet Diabetes & Endocrinology in 2018.
The fully automated and integrated centrifugation process offers seamless integration of 3C Patch Wound Management System into the clinic workflow.
18ml blood collection by vacuum
3C Patch® Technology generates a 3C Patch® in a table top centrifuge
Open the device and transfer the 3C Patch® to the wound
Effective April 13, 2021, Medicare covers the 3C Patch® for the treatment of chronic non-healing diabetic wounds for 20 weeks.
1. Game F., Jeffcoate W., Tarnow L., Jacobsen JL., Whitham DJ., Harrison EF., Ellender SJ., Fitzsimmons D., LöndahlM., LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked randomized controlled trial. Lancet Diabetes Endocrinology. 2018; 6(11): 870-878.
2. https://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development/Autologous-Platelet-rich-Plasma, NCT02224742
3. Rayman G., Vas P., Dhatariya K., Driver V., Hartemann A., Londahl M., Piaggesi A., Apelqvist J., Attinger C.,Game F., on behalf of the International Working Group of the Diabetic Foot (IWGDF), IWGDF Guideline on interventions to enhance healing of foot ulcers in persons with diabetes, Part of the 2019 IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease.
